BlackRock, Inc. 13D and 13G filings for BioLife Solutions, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-23 4:13 pm Sale | 2023-12-31 | 13G | BioLife Solutions, Inc. BLFS | BlackRock Inc. BLK | 5,424,116 12.300% | -53,010 (-0.97%) | Filing |
| 2023-01-26 08:52 am Unchanged | 2022-12-31 | 13G | BioLife Solutions, Inc. BLFS | BlackRock Inc. BLK | 5,477,126 12.800% | 0 (Unchanged) | Filing |
| 2023-01-20 09:43 am Purchase | 2022-12-31 | 13G | BioLife Solutions, Inc. BLFS | BlackRock Inc. BLK | 5,477,126 12.800% | 583,923 (+11.93%) | Filing |
| 2022-07-08 4:56 pm Purchase | 2022-06-30 | 13G | BioLife Solutions, Inc. BLFS | BlackRock Inc. BLK | 4,893,203 11.500% | 1,238,146 (+33.87%) | Filing |
| 2022-02-01 5:08 pm Sale | 2021-12-31 | 13G | BioLife Solutions, Inc. BLFS | BlackRock Inc. BLK | 3,655,057 8.800% | -873,666 (-19.29%) | Filing |
| 2021-09-09 4:20 pm Purchase | 2021-08-31 | 13G | BioLife Solutions, Inc. BLFS | BlackRock Inc. BLK | 4,528,723 11.100% | 4,528,723 (New Position) | Filing |